Filing metadata

Accession number
0000950170-24-140871
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Dec 27, 2024
Reporting period
Dec 24, 2024
Description
Insider transaction

Explore SEC Filings Hub